The Valley Desk

NCT01849263 · Interventional trial

Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma

Overall registry status Active not recruiting

Phase 2

Conditions Grade 3a Follicular Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Refractory Follicular Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov